Insider · CIK 0001582392
John Bernard Payne
Files at ZIVO (Zivo Bioscience, Inc.). First filing Oct 16, 2024, latest Jan 28, 2026.
In brief
John Bernard Payne files SEC Form 4 as CEO, president and director at ZIVO (Zivo Bioscience, Inc.). Since Oct 16, 2024, John Bernard Payne has reported 2 open-market buys worth $200k and 0 open-market sells worth $0, the latest filed on Jan 28, 2026.
A track record needs three past buys with six months of prices behind them; John Bernard Payne has 1, so none is measured yet.
The newest scored trade: bought $100k of ZIVO on Jan 26, 2026, filed Jan 28, 2026, scored 68 (notable). In the last 12 months: 1 buy worth $100k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZIVO: Zivo Bioscience, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | Zivo Bioscience, Inc. | $100k 11,709 shares | +148% | +40% from low-55% from high | |
| 53Moderate | Zivo Bioscience, Inc. | $100k 6,343 shares | +405% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stock | +11,709 | $8.54 | $100k | 19,618 | Jan 28, 2026 |
| Oct 16, 2024 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stock | +6,343 | $15.76 | $100k | 7,909 | Oct 16, 2024 |
| Oct 16, 2024 | ZIVO Zivo Bioscience, Inc. | POpen-market purchase Common Stock Warrantderivative | +634 | $15.77 | $9,995 | 634 | Oct 16, 2024 |
Questions about John Bernard Payne
Answered from the filings on this page, as of the latest one.
Is John Bernard Payne buying or selling?
In the last 12 months John Bernard Payne reported 1 open-market buy worth $100k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of ZIVO on Jan 26, 2026. Grants, option exercises and tax withholding are not counted.
How did John Bernard Payne's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Bernard Payne has 1.
Where does John Bernard Payne file Form 4?
John Bernard Payne has filed Form 4 at ZIVO (Zivo Bioscience, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.